Chromium chloride inhibits TNFalpha and IL-6 secretion in isolated human blood mononuclear cells exposed to high glucose.
Jain
S K
SK
Department of Pediatrics, Louisiana State University Health Sciences Center, Shreveport 71130, USA. sjain@lsuhsc.edu
Lim
G
G
D002478:Cells, Cultured; D002712:Chlorides / Q000494:pharmacology*; D017608:Chromium Compounds / Q000494:pharmacology*; D003925:Diabetic Angiopathies / Q000178:diet therapy / Q000378:metabolism; D019587:Dietary Supplements; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism*; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000378:metabolism*; D009203:Myocardial Infarction / Q000178:diet therapy / Q000209:etiology / Q000378:metabolism; D009262:Nails / Q000378:metabolism; D012307:Risk Factors; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D014657:Vasculitis / Q000178:diet therapy / Q000209:etiology / Q000378:metabolism
D002712:Chlorides; D017608:Chromium Compounds; C508600:IL6 protein, human; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; C017133:chromous chloride; D005947:Glucose